Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.jubilantingrevia.com | |
Market Cap | 7,268.00 Cr. | |
Enterprise Value(EV) | 7,969.39 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 16.26 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 28.07 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.71 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 169.52 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.69 | Calculated using Price: 456.30 |
Dividend Yield | 1.10 | Period Ending 2023-03 |
No. of Shares Subscribed | 15.93 Cr. | 159,281,139 Shares |
FaceValue | 1 | |
About Jubilant Ingrevia Ltd. | ||
The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company's portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. |
1 Day |
|
+0.63% |
1 Week |
|
+6.49% |
1 Month |
|
+10.39% |
3 Month |
|
-11.35% |
6 Month |
|
+8.43% |
1 Year |
|
-13.05% |
2 Year |
|
-21.89% |
5 Year |
|
|
10 Year |
|
4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 5.65 | 21.89 | 12.07 | ||
Return on Capital Employed (%) | 6.86 | 28.84 | 16.01 | ||
Return on Assets (%) | -332.00 | 3.23 | 13.34 | 7.66 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 1,923 | 2,433 | 2,666 | 2,700 | |
Non Curr. Liab. | 549 | 296 | 403 | 567 | ||
Curr. Liab. | 0 | 894 | 1,053 | 1,180 | 1,190 | |
Minority Int. | ||||||
Equity & Liab. | 0 | 3,366 | 3,782 | 4,249 | 4,457 | |
Non Curr. Assets | 1,943 | 2,018 | 2,431 | 2,679 | ||
Curr. Assets | 0 | 1,424 | 1,765 | 1,818 | 1,778 | |
Misc. Exp. not W/O | ||||||
Total Assets | 0 | 3,366 | 3,782 | 4,249 | 4,457 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 684 | 4,949 | 4,773 | 4,398 | ||
Other Income | 3 | 31 | 33 | 33 | ||
Total Income | 687 | 4,981 | 4,806 | 4,431 | ||
Total Expenditure | 0 | -567 | -4,118 | -4,226 | -3,911 | |
PBIDT | 0 | 120 | 863 | 581 | 521 | |
Interest | -7 | -31 | -22 | -36 | ||
Depreciation | -22 | -123 | -122 | -126 | ||
Taxation | -23 | -232 | -129 | -99 | ||
Exceptional Items | -13 | |||||
PAT | 0 | 54 | 477 | 308 | 259 | |
Minority Interest | ||||||
Share Associate | 0 | |||||
Other Related Items | ||||||
Consolidated Net Profit | 0 | 54 | 477 | 308 | 259 | |
Adjusted EPS | -3 | 3 | 30 | 19 | 16 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 112 | 453 | 462 | ||
Cash Fr. Inv. | -44 | -72 | -472 | ||
Cash Fr. Finan. | 0 | -72 | -418 | 42 | |
Net Change | 0 | -4 | -37 | 32 | |
Cash & Cash Eqvt | 0 | 73 | 38 | 73 |
Fri, 24 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor/Analyst Meeting |
Fri, 24 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Investor/Analyst Meetings |
Mon, 20 Nov 2023
Intimation Of Record Date For Maturity Of Commercial Paper Intimation of Record Date for maturity of Commercial Paper |
Fri, 08 Dec 2023 |
|
|
|
|
|